Show simple item record

dc.contributor.authorNash, P
dc.contributor.authorBehrens, F
dc.contributor.authorOrbai, A
dc.date.accessioned2020-08-24T01:06:47Z
dc.date.available2020-08-24T01:06:47Z
dc.date.issued2019
dc.identifier.issn2056-5933
dc.identifier.doi10.1136/rmdopen-2018-000692corr1
dc.identifier.urihttp://hdl.handle.net/10072/396667
dc.description.abstractNash P, Behrens F, Orbai A, et al. Ixekizumab is efficacious when used alone or when added to conventional synthetic disease-modifying antirheumatic drugs (cDMARDs) in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor inhibitors. RMD Open 2018;4:e000692. doi: 10.1136/rmdopen-2018-000692 This article has been corrected since it first published. There were some copyediting errors which have been rectified now.
dc.languageEnglish
dc.publisherBMJ Publishing Group
dc.relation.ispartofpagefrom1 pages
dc.relation.ispartofpageto1 pages
dc.relation.ispartofissue1
dc.relation.ispartofjournalRMD Open
dc.relation.ispartofvolume5
dc.subject.fieldofresearchClinical Sciences
dc.subject.fieldofresearchcode1103
dc.subject.keywordsScience & Technology
dc.subject.keywordsLife Sciences & Biomedicine
dc.subject.keywordsRheumatology
dc.titleCorrection: Ixekizumab is efficacious when used alone or when added to conventional synthetic disease-modifying antirheumatic drugs (cDMARDs) in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor inhibitors
dc.typeJournal article
dc.type.descriptionC3 - Articles (Letter/ Note)
dcterms.bibliographicCitationNash, P; Behrens, F; Orbai, A, Ixekizumab is efficacious when used alone or when added to conventional synthetic disease-modifying antirheumatic drugs (cDMARDs) in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor inhibitors (vol 4, e000692, 2018), RMD Open, 2019, 5 (1)
dcterms.licensehttp://creativecommons.org/licenses/by-nc/4.0
dc.date.updated2020-08-24T00:59:40Z
dc.description.versionPublished
gro.rights.copyright© Author (s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, any changes made are indicated, and the use is non-commercial.
gro.hasfulltextFull Text
gro.griffith.authorNash, Peter


Files in this item

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record